Free shipping on all orders over $ 500

RO4929097

Cat. No. M2015

All AbMole products are for research use only, cannot be used for human consumption.

RO4929097 Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 90 In stock
2mg USD 50 In stock
5mg USD 80 In stock
10mg USD 150 In stock
50mg USD 450 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

RO4929097 is a potent and selective inhibitor of gamma-secretase, with IC50 of 4 nM and also inhibits Aβ40 and ICN with EC50 of 14 nM and 5 nM, producing inhibitory activity of Notch signaling in tumor cells. RO4929097 inhibits Notch processing in tumor cells as measured by the reduction of intracellular Notch expression by Western blot. The RO4929097 IC50 in cell-free and cellular assays is in the low nanomolar range with >100-fold selectivity with respect to 75 other proteins of various types (receptors, ion channels, and enzymes). RO4929097 induced significant differences in event-free survival (EFS) distribution compared to control in 6 of 26 (23%) of the evaluable solid tumor xenografts and in 0 of 8 (0%) of the evaluable ALL xenografts. In human primary melanoma cell lines, RO4929097 decreased the levels of NOTCH transcriptional target HES1. Moreover, RO4929097 affected the growth of human primary melanoma xenograft in NOD/SCID/IL2gammaR-/- mice and inhibited subsequent tumor formation in a serial xenotransplantation model, suggesting that inhibition of NOTCH signaling suppresses the tumor initiating potential of melanoma cells. In addition, RO4929097 decreased tumor volume and blocked the invasive growth pattern of metastatic melanoma cell lines in vivo.

Customer Product Validations & Biological Datas
Source Anticancer Drugs (2015). Figure 2. RO4929097
Method MTS assay
Cell Lines NEM78 cells
Concentrations 3 μmol/l
Incubation Time 48 h
Results RO4929097 reduces Notch effectors expression and cellular density and shows antiproliferative activity in NEM78 ependymoma cells.
Chemical Information
Molecular Weight 469.4
Formula C22H20F5N3O3
CAS Number 847925-91-1
Solubility (25°C) DMSO 64 mg/mL
Storage -20°C, sealed
References

[1] Kolb EA, et al. Pediatr Blood Cancer. Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ-secretase inhibitor targeting notch signaling.

[2] Huynh C, et al. PLoS One. The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma.

[3] Luistro L, et al. Cancer Res. Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties.

Related Gamma-secretase/Beta-secretase Products
DAPT

DAPT (GSI-IX) is a γ-secretase inhibitor with IC50 values of 115 and 200 nM for total Aβ and Aβ42 respectively. DAPT inhibits the activation of Notch 1 signaling.

BMS-708163

BMS-708163 (Avagacestat) is a selective γ-secretase inhibitor (IC50 = 0.3 nM).

MK-0752

MK-0752 is a potent, oral inhibitor of γ-secretase with IC50 of 5 nM in human SH-SY5Y cells.

LY-411575

LY-411575 is potent and selective small molecule γ-secretase inhibitor with IC50 of 0.1 nM for APP23 and APP51/16 primary neurons.

LY2811376

LY2811376 is an orally available, non-peptidic β-secretase inhibitor with IC50 of 239 nM-249 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: RO4929097 supplier, Gamma-secretase/Beta-secretase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.